Zimmer Biomet Holdings (ZBH) Cash from Financing Activities (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Cash from Financing Activities of -$369.2 million for Q1 2026, down 164.16% year-over-year from $575.4 million in Q1 2025, and up 58.84% quarter-over-quarter from -$897.0 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$369.2 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 164.16% year-over-year to -$369.2 million; the TTM figure through Mar 2026 stood at -$618.6 million (down 538.72% YoY), while the FY2025 annual figure was $326.0 million, up 167.29% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$369.2 million, up from -$897.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $575.4 million in Q1 2025, with the low at -$897.0 million in Q4 2025.
- The 5-year median for Cash from Financing Activities is -$146.0 million (2022), against an average of -$121.6 million.
- The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities slumped 415.9% in 2022, then surged 1248.5% in 2025.
- Zimmer Biomet Holdings' Cash from Financing Activities stood at -$313.4 million in 2022, then gained by 19.78% to -$251.4 million in 2023, then gained by 4.3% to -$240.6 million in 2024, then tumbled by 272.82% to -$897.0 million in 2025, then surged by 58.84% to -$369.2 million in 2026.
- Business Quant data shows ZBH's Cash from Financing Activities at -$369.2 million in Q1 2026, -$897.0 million in Q4 2025, and $483.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.29 Bn | 18.88 Bn | 1.54 Bn | -271.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -271.10 Mn |
| Jun 30, 2026 | -271.10 Mn |
| Mar 31, 2026 | -369.20 Mn |
| Mar 31, 2026 | -369.20 Mn |
| Dec 31, 2025 | -897.00 Mn |
| Dec 31, 2025 | -897.00 Mn |
| Sep 30, 2025 | 483.80 Mn |
| Sep 30, 2025 | 483.80 Mn |
| Jun 30, 2025 | 163.80 Mn |
| Jun 30, 2025 | 163.80 Mn |
| Mar 31, 2025 | 575.40 Mn |
| Mar 31, 2025 | 575.40 Mn |
| Dec 31, 2024 | -240.60 Mn |
| Dec 31, 2024 | -240.60 Mn |
| Sep 30, 2024 | -101.90 Mn |
| Sep 30, 2024 | -101.90 Mn |
| Jun 30, 2024 | -91.90 Mn |
| Jun 30, 2024 | -91.90 Mn |
| Mar 31, 2024 | -50.10 Mn |
| Mar 31, 2024 | -50.10 Mn |